Efficient chimeric antigen receptor targeting of a central epitope of CD22
Nicholas Casey(Oslo University Hospital), Sébastien Wälchli(Oslo University Hospital), Benjamin Caulier(Oslo University Hospital), Agnieszka Graczyk‐Jarzynka(Medical University of Warsaw), Anne Fåne(Oslo University Hospital), Pierre Dillard(Oslo University Hospital), Elżbieta Patkowska(Institute for Transfusion Medicine), Sarah E. Josefsson(Oslo University Hospital), Klaudyna Fidyt(Polish Academy of Sciences), Marta Krawczyk(Medical University of Warsaw), Małgorzata Firczuk(Medical University of Warsaw), Magdalena Winiarska(Medical University of Warsaw), Clara Helena Klee(Oslo University Hospital), Else Marit Inderberg(Oslo University Hospital), June H. Myklebust(Oslo University Hospital), Erlend B. Smeland(Norwegian Cancer Society), Hakan Köksal(University of Zurich)
Cited by 6
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k
Oncogenically active MYD88 mutations in human lymphoma
|Nature|2010|1.5k
Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells
|New England Journal of Medicine|2004|1.4k